MedTrace Logo

Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia

NCT01581528 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood, tissue, and bone marrow from patients with cancer in the laboratory may help doctors identify learn more about biomarkers related to cancer. It may also help doctors to find better ways to treat cancer.

PURPOSE: This research studies samples from patients with T-cell acute lymphoblastic leukemia (T-ALL).

Conditions

Interventions

GENETIC

gene expression analysis

OTHER

cell culture procedure

OTHER

flow cytometry

OTHER

laboratory biomarker analysis

OTHER

metabolic assessment

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Jeffrey C. Rathmell, PhD · Duke Cancer Institute

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01581528 on ClinicalTrials.gov